A first-in-human (FIH) phase 1 study of SHR-A1921, a TROP-2 targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors Jie Wang,Lin Wu,Zhengbo Song,Xingya Li, Caigang Liu,Tianshu Liu, Yiwen Wu,Ze Zhang,Shuni WangCANCER RESEARCH（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
